Relief of symptoms associated with peptic ulcer of the stomach or duodenum, gastritis, hyperacidity, hiatal hernia, indigestion and other gastrointestinal disorders (heartburn, bloating).
Composition:
1 tabl for chewing and chewing contains 200 mg of aluminum hydroxide, 200 mg of Magnesium hydroxide and 25 mg of simethicone.
Action:
Preparation with combined action of ingredients. The preparation works by neutralizing hydrochloric acid and reducing excessive amount of intestinal gases. Aluminum and magnesium preparations protect the mucous membrane of the esophagus, stomach and duodenum. Simethicone reduces the surface tension of gas bubbles in the gastrointestinal tract. This phenomenon occurs at the interface between the liquid content of the gastrointestinal tract and the gas located there. This facilitates both the absorption of gas through the intestinal wall into the bloodstream and its excretion outside due to peristaltic motions. The onset of action in the form of hydrochloric acid neutralization and regression of pain in patients with heartburn occurs 10-15 minutes after taking the preparation. The effect lasts for up to 3 h or longer, especially if the neutralizing drug was taken after a meal.
Contraindications:
Hypersensitivity to the active substances or to any of the excipients. Severe renal failure, especially treated with dialysis. It should not be used in children under the age of 6 years.
Precautions:
Neutralizing preparations can alter the absorption of many drugs. Between the use of the preparation and other medications used orally should be kept for at least a 2 h break.Antacids may mask the symptoms of gastrointestinal bleeding in patients using NSAIDs. Due to the content of aspartame, the preparation should not be used in patients with phenylketonuria. The preparation contains sorbitol and should not be used in patients with a rarely occurring fructose intolerance.
Pregnancy and lactation:
The preparation should not be used during pregnancy and during breastfeeding.
Side effects:
Hypersensitivity reactions, diarrhea, constipation, flatulence, hypophosphataemia, hypocalcaemia, hypercalciuria, hypermascemia in patients with renal insufficiency, dementia or encephalopathy during long-term use in patients with renal insufficiency (especially in dialysis patients), osteomalacia and osteodystrophy in patients for a long time using high doses of the drug.
Dosage:
Orally. Adults and children from 6 years: 1-3 tabl. between meals, at bedtime and in case of stomach problems. The maximum daily dose is 12 tabl. The maximum dose should not be used for more than 2 weeks. Do not swallow the tablets whole.
(C)
